Skip to main content

Form 8.3 – Segro Plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Jupiter Fund Management Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of Offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree SEGRO plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date dealing undertaken:        For an opening position disclosure, state...

Continue reading

Nightfood Holdings Signs LOI to Acquire 51% of Jiun Jiang Enterprise

Proposal establishes a platform for semiconductor automation, AI infrastructure, and advanced manufacturing growth Proposed all-stock transaction features performance-based consideration linked to PCAOB-audited revenue milestones Enterprise value benchmarks range from $100 million up to $1.2 billion LOS ANGELES, June 25, 2026 (GLOBE NEWSWIRE) — via IBN — Nightfood Holdings, Inc. (OTCQB: NGTF), doing business as TechForce Robotics (“TechForce” or the “Company”), today announced that it has executed a non-binding Letter of Intent (the “LOI”) to acquire a 51% controlling interest in Jiun Jiang Enterprise Co., Ltd. (“JJ Enterprise”), a Taiwan-based manufacturer of precision industrial, advanced packaging and semiconductor automation and thermal interface material manufacturing systems, robotics, and intelligent manufacturing...

Continue reading

Firefly Aerospace Acquires Space-ng to Advance Future of Autonomous Space Operations

Space-ng’s vision navigation system utilized during Blue Ghost Mission 1 strengthens Firefly’s capabilities to enable repeatable missions to the Moon and beyondCEDAR PARK, Texas, June 25, 2026 (GLOBE NEWSWIRE) — Firefly Aerospace (Nasdaq: FLY), a market leading space and defense technology company, today announced the acquisition of Space-ng Inc. (“Space-ng”), a leader in AI-powered vision navigation and autonomous guidance systems. The acquisition brings proven spacecraft software and camera hardware for Firefly’s Blue Ghost landers and Elytra orbital vehicles, bolstering Firefly’s capabilities to advance the future of autonomous space operations for missions to the Moon, Mars, and beyond. Space-ng’s vision navigation software was utilized during Firefly’s historic Blue Ghost Mission 1 to determine position...

Continue reading

Onex Partners and Co-Investors to Acquire AirSprint, Canada’s Leader in Fractional Jet Ownership

Founder, CEO and select shareholders to remain investors as AirSprint enters its next chapter of growth All amounts in U.S. dollars unless otherwise stated  TORONTO, June 25, 2026 (GLOBE NEWSWIRE) — Onex Partners (“Onex”) today announced that the Onex Partners Opportunities Fund, TriWest Capital Partners (“TriWest”) and certain other co-investors have agreed to acquire AirSprint Inc. (“AirSprint”), the largest fractional jet operator in Canada. AirSprint’s Founder & Chairman Judson Macor, President & CEO James Elian and certain of its current shareholders will remain investors following closing of the transaction. Headquartered in Calgary, Alberta, with offices in Toronto and Montréal, AirSprint operates the largest fractional fleet of private aircraft in Canada. AirSprint provides coast-to-coast access, enabling Fractional...

Continue reading

Form 8.5 (EPT/RI) – Pharos Energy Plc

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code” 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Pharos Energy Plc(c)        Name of the party to the offer with which exempt principal trader is connected: Ratio Petroleum Energy LP(d)        Date dealing undertaken: 24 June 2026(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a)        Purchases and salesClass of relevant...

Continue reading

Form 8.3 – [ANIMALCARE GROUP PLC – 24 06 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 24 06 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Western Union and Intermex Provide an Update on Pending Acquisition of Intermex

DENVER and MIAMI, June 24, 2026 (GLOBE NEWSWIRE) — The Western Union Company (“Western Union”) (NYSE: WU) and International Money Express, Inc. (“Intermex”) (NASDAQ: IMXI) today provided an update on the approval process and timeline for Western Union’s pending acquisition of Intermex. To date, money transmission regulators in 51 applicable U.S. states and territories and in all international jurisdictions have provided their approval of or non-objection to the acquisition, and approval or non-objection is currently pending from one U.S. state. Western Union and Intermex remain actively engaged in discussions with regulators, including the New York State Department of Financial Services, to obtain the final regulatory approval. Western Union and Intermex anticipate closing the transaction as soon as reasonably practicable upon...

Continue reading

Passage Bio and Remix Therapeutics Announce Merger Agreement

Combined company to operate as Remix Therapeutics and advance Remix’s pipeline of novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin Remix’s lead program, REM-422, is an orally available mRNA degrader targeting MYB, a historically undruggable transcription factor implicated across multiple cancers Concurrent oversubscribed $100 million private placement financing of Remix expected to fund combined company operations into 2028, supporting delivery of several clinical readouts for REM-422 in 2027 Companies to hold joint conference call on June 24, 2026 at 4:30 PM ET PHILADELPHIA and WATERTOWN, Mass., June 24, 2026 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG) (“Passage Bio”) and Remix Therapeutics, Inc. (“Remix”), a clinical-stage biotechnology company developing...

Continue reading

Riviera Partners Acquires Lateral Labs, Expanding Its AI and Machine Learning Talent Search and Placement Capabilities

Acquisition unites industry’s leading tech-focused executive search firm with pioneering AI-native recruiting organization San Francisco , June 24, 2026 (GLOBE NEWSWIRE) — San Francisco, CA — June 24, 2026 — Riviera Partners, the leading global executive search firm specializing in technology leadership, today announced the acquisition of Lateral Labs, a specialized recruiting firm serving top AI startups.   The acquisition comes as companies remain challenged to meet the demand of organizational AI readiness. Adding Lateral Labs positions Riviera Partners to help companies meet that challenge across the full arc of an AI company’s growth, offering executive and technical talent search from seed-stage startup through IPO.  Lateral Labs partners with some of the most demanding technical teams in AI, including Cursor, ElevenLabs,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.